Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs sufentanil for postoperative nausea and vomiting after laparoscopic sleeve gastrectomy
ChiCTR2400090776Phase 4Not yet recruiting
- Sponsor
- Taizhou People's Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in obesity and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Taizhou People's Hospital. Primary endpoint: postoperative nausea and vomiting. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
obesitypostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2400090776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090776.